Furthermore, APS treatment inhibited cardiac H2O2 formation, reduced cardiac oxidative stress/damage, and increased SOD activity in cardiomyocytes from heterozygous SOD2+/- knockout hearts with or without diabetes. This evidence concerns the gene SOD1 and diabetes mellitus.